Qinglin L. Peng

Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 75 publications

Anti-Ro52 antibodies in idiopathic inflammatory myopathies: clinical significance across myositis-specific antibody-defined subgroups.

Anti-Ro52 antibodies in idiopathic inflammatory myopathies: clinical significance across myositis-specific antibody-defined subgroups.

Journal: Rheumatology (Oxford, England)

Published: April 13, 2026

Etiopathogenesis of Immune-Mediated Necrotizing Myopathy: A Comprehensive Review of Recent Advances.

Etiopathogenesis of Immune-Mediated Necrotizing Myopathy: A Comprehensive Review of Recent Advances.

Journal: CNS neuroscience & therapeutics

Published: December 17, 2025

Development and Validation of the ALARN Model: A Predictive Mortality Score for Antisynthetase Syndrome.

Development and Validation of the ALARN Model: A Predictive Mortality Score for Antisynthetase Syndrome.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: November 21, 2025

Dysregulation of YTHDF2 promotes the over expression of interferon beta in anti-MDA5 antibody-positive dermatomyositis.

Dysregulation of YTHDF2 promotes the over expression of interferon beta in anti-MDA5 antibody-positive dermatomyositis.

Journal: Arthritis research & therapy

Published: October 14, 2025

Interferon-β Triggers Z-DNA Binding Protein 1-Mediated PANoptosis in T Cells of Anti-Melanoma Differentiation-Associated Protein 5 Antibody-Positive Dermatomyositis.

Interferon-β Triggers Z-DNA Binding Protein 1-Mediated PANoptosis in T Cells of Anti-Melanoma Differentiation-Associated Protein 5 Antibody-Positive Dermatomyositis.

Journal: Immunology

Published: September 04, 2025

A serum biomarker-based index for predicting progressive pulmonary fibrosis in patients with anti-synthetase syndrome: the LOCCM index.

A serum biomarker-based index for predicting progressive pulmonary fibrosis in patients with anti-synthetase syndrome: the LOCCM index.

Journal: Respiratory research

Published: August 07, 2025

High prevalence of osteonecrosis of the femoral head in anti-MDA5 antibody-positive dermatomyositis.

High prevalence of osteonecrosis of the femoral head in anti-MDA5 antibody-positive dermatomyositis.

Journal: QJM : monthly journal of the Association of Physicians

Published: July 23, 2025

Anti-interferon-α antibodies associate with disease activity and prognosis in anti-MDA5-positive dermatomyositis.

Anti-interferon-α antibodies associate with disease activity and prognosis in anti-MDA5-positive dermatomyositis.

Journal: Arthritis research & therapy

Published: April 21, 2025

The FLATCAN Model: A Novel Score for Predicting Mortality Risk in Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis.

The FLATCAN Model: A Novel Score for Predicting Mortality Risk in Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis.

Journal: Respirology (Carlton, Vic.)

Published: February 07, 2025

Long-term outcomes of idiopathic inflammatory myopathies: a large-scale longitudinal cohort study.

Long-term outcomes of idiopathic inflammatory myopathies: a large-scale longitudinal cohort study.

Journal: Journal of autoimmunity

Published: January 02, 2025

Antimelanoma differentiation antigen 5-positive dermatomyositis: an update.

Antimelanoma differentiation antigen 5-positive dermatomyositis: an update.

Journal: Current opinion in rheumatology

Published: July 15, 2024

Association of anti-HMGCR antibodies of the IgM isotype with refractory immune-mediated necrotizing myopathy.

Association of anti-HMGCR antibodies of the IgM isotype with refractory immune-mediated necrotizing myopathy.

Journal: Arthritis research & therapy

Published: July 01, 2024

Showing 1-12 of 75

Last Updated: 09/26/2026